Aescap Venture is a new Venture Capital Company targeted at European biomedical companies. Our added value is based on best of breed investment managers. All with a proven track record and the ability to coach and stimulate entrepreneurs in the creation and growth of their companies.
Copyright © 2012 Affectis Pharmaceuticals AG. All Rights Reserved.
